Sep 2026· Journal of International Medical Research· Vol 54· 0 citations· 31 references
Medicine
TL;DR
Evidence is provided that Agnuside serves as a potential therapeutic candidate for vascular dementia through modulation of angiogenesis-related genes and activation of AKT/ERK signaling.
Abstract
Objective Vascular dementia is the second most common cause of cognitive impairment in older adults, yet effective pharmacological treatments remain limited. Agnuside, a naturally occurring compound with antioxidant and anti-inflammatory properties, has shown vascular-protective potential; however, its role in vascular dementia remains unclear. Methods A mouse model of permanent bilateral common carotid artery occlusion was established to evaluate the effects of Agnuside. Cognitive function was assessed using the Morris water maze. Cerebral blood flow, tissue injury, and hippocampal cornu ammonis 1 neuronal apoptosis were evaluated using laser speckle imaging, triphenyltetrazolium chloride staining, Nissl staining, and terminal deoxynucleotidyl transferase dUTP nick-end labeling. Transcriptomic and pathway enrichment analyses were performed, and key targets were validated using quantitative real-time polymerase chain reaction and Western blotting. Results Agnuside improved spatial learning and memory, increased cerebral blood flow, reduced histopathological damage, and decreased neuronal apoptosis. Angiogenesis-related genes (Mmp3, IL1RN, and ALAS2) were differentially expressed, and selected genes were validated using quantitative real-time polymerase chain reaction. The PI3K-AKT and MAPK pathways were significantly enriched, and Agnuside restored AKT and ERK1/2 phosphorylation. Conclusions Agnuside exerts neurovascular protective effects in mice with vascular dementia, likely through modulation of angiogenesis-related genes and activation of AKT/ERK signaling. These findings provide evidence that Agnuside serves as a potential therapeutic candidate for vascular dementia.
Rosemary inhalation can improve behavior and cognition in VCI rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy and intervention with EX527 attenuated this protective effect.
Feng-Fei Shi, En-Si Hong, Jie-Wei Bao et al.· Iranian Journal of Basic Med...· 0 citations
It is demonstrated that IGF-1/p-Akt/VEGF pathway activation in pvMΦ plays a crucial role in Maresin1-mediated angiogenesis in CCH rats, and the increased VEGF expression was predominantly mediated by perivascular macrophage (pvMΦ) activation.
Hao Song, Miao-Yu Du, Hao-Ying He et al.· Neurochemical Research· 0 citations
Objective-Methods:Chronic cerebral-hypoperfusion is a key contributor to vascular cognitive impairment, with blood-brain barrier (BBB) dysfunction proposed as an early driver of white matter injury. The temporal-evolution and regional-heterogeneity of BBB-leakage remain poorly characterized in vivo. We longitudinally a...
Ana Sampedro-Viana, Sabela Fernández-Rodicio, José Castillo et al.· Journal of Cerebral Blood Fl...· 0 citations
Blood-brain barrier (BBB) dysfunction is increasingly recognized as an early pathological event in sporadic Alzheimer’s disease (AD), which represents over 95% of cases. Vascular risk factors and cerebral insulin resistance are considered potential contributors to its initiation. This review synthesizes evidence availa...
Karen León-Arcia, Humberto Martínez-Orozco, Magdalena Guerra-Crespo et al.· Journal of Molecular Neurosc...· 0 citations
Therapeutic for Alzheimer’s disease (AD) remains a pressing medical challenge in the field of neuroscience. Natural compounds with structural diversity and multi-target regulatory properties have attracted increasing attention for the treatment of complex neurodegenerative disorders. Fraxetin, previously identified thr...
Jun Zhao, Yi-Ming Bai, Chao Wang et al.· Journal of Neuroimmune Pharm...· 0 citations
Chronic cerebral hypoperfusion (CCH) is a major cause of progressive cognitive decline and vascular dementia in older adults. Modified Dioscorea Pills (MDP), a traditional Chinese medicinal formula, has demonstrated clinical efficacy for dementia treatment. However, the effects and molecular mechanisms of MDP on th...
Qian Xu, Dan He, Hong-Bing Li· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.